Credit Suisse’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,375
| Closed | -$193K | – | 3661 |
|
|
2022
Q4 | $193K | Buy |
12,375
+55
| +0.4% | +$858 | ﹤0.01% | 3177 |
|
|
2022
Q3 | $160K | Sell |
12,320
-448
| -4% | -$5.82K | ﹤0.01% | 3300 |
|
|
2022
Q2 | $179K | Hold |
12,768
| – | – | ﹤0.01% | 3352 |
|
|
2022
Q1 | $183K | Sell |
12,768
-22,461
| -64% | -$322K | ﹤0.01% | 3376 |
|
|
2021
Q4 | $480K | Sell |
35,229
-24,002
| -41% | -$327K | ﹤0.01% | 3047 |
|
|
2021
Q3 | $970K | Sell |
59,231
-27,566
| -32% | -$451K | ﹤0.01% | 2606 |
|
|
2021
Q2 | $1.46M | Buy |
86,797
+64,951
| +297% | +$1.09M | ﹤0.01% | 2382 |
|
|
2021
Q1 | $399K | Sell |
21,846
-18,521
| -46% | -$338K | ﹤0.01% | 3062 |
|
|
2020
Q4 | $735K | Sell |
40,367
-136,323
| -77% | -$2.48M | ﹤0.01% | 2769 |
|
|
2020
Q3 | $3.15M | Sell |
176,690
-322,074
| -65% | -$5.75M | ﹤0.01% | 1544 |
|
|
2020
Q2 | $8.94M | Buy |
498,764
+423,166
| +560% | +$7.59M | 0.01% | 1039 |
|
|
2020
Q1 | $1.15M | Sell |
75,598
-101,223
| -57% | -$1.54M | ﹤0.01% | 2019 |
|
|
2019
Q4 | $3.49M | Buy |
176,821
+44,748
| +34% | +$883K | ﹤0.01% | 1655 |
|
|
2019
Q3 | $2.27M | Sell |
132,073
-341,690
| -72% | -$5.88M | ﹤0.01% | 1848 |
|
|
2019
Q2 | $8.39M | Buy |
473,763
+273,855
| +137% | +$4.85M | 0.01% | 1074 |
|
|
2019
Q1 | $4.07M | Sell |
199,908
-1,167,972
| -85% | -$23.8M | ﹤0.01% | 1478 |
|
|
2018
Q4 | $23M | Buy |
+1,367,880
| New | +$23M | 0.02% | 592 |
|